Search Results - "Glehen O"

Pattern of failures in gastric cancer patients with lymph node involvement treated by surgery, intraoperative and external beam radiotherapy

Authors: Glehen, O. Peyrat, P. Beaujard, A.C. et al.

Source: Radiotherapy & Oncology. May2003, Vol. 67 Issue 2, p171. 5p.

Subjects: Cancer relapse, Gastric diseases

Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: A multi-institutional study of 1290 patients.

Authors: Glehen O Gilly FN Boutitie F et al.

Source: Cancer (0008543X). 12/15/2010, Vol. 116 Issue 24, p5608-5618. 11p.

Nouveautés thérapeutiques dans la prise en charge des carcinoses péritonéales d'origine digestive : chirurgie de cytoréduction et chimiothérapie intrapéritonéale

Alternate Title: Therapeutic innovations in the management of peritoneal carcinomatosis from digestive origin: cytoreductive surgery and intraperitoneal chemotherapy

Authors: Glehen, O. Cotte, E. Brigand, C. et al.

Source: Revue de Médecine Interne. May2006, Vol. 27 Issue 5, p382-391. 10p.

Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model.

Authors: Glehen, O. Stuart, O. A. Mohamed, F. et al.

Source: Cancer Chemotherapy & Pharmacology. Jul2004, Vol. 54 Issue 1, p79-84. 6p.

Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin.

Authors: Glehen, O. Cotte, E. Schreiber, V. et al.

Source: British Journal of Surgery. Jun2004, Vol. 91 Issue 6, p747-754. 8p. 5 Charts, 2 Graphs.

Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia.

Authors: Glehen O Mohamed F Gilly FN

Source: Lancet Oncology. Apr2004, Vol. 5 Issue 4, p219-228. 10p.

Hyperthermic chemotherapy for peritoneal primary and digestive carcinomatoses

Alternate Title: Chimiohyperthermie pour carcinoses péritonéales primitives et d’origine digestive

Authors: Slim, K. Glehen, O. Gilly, F.N.

Source: Annales de Chirurgie. Nov2003, Vol. 128 Issue 9, p580-589. 10p.

Small bowel length in Crohn's disease.

Authors: Glehen, O. Lifante, J. C. Vignal, J. et al.

Source: International Journal of Colorectal Disease. Sep2003, Vol. 18 Issue 5, p423-427. 5p. 6 Charts, 1 Graph.

CHIP et cancer de l’ovaire : en finir avec les préjugés

Alternate Title: HIPEC and ovarian carcinoma: Base judgment on evidence

Authors: Bakrin, N. Glehen, O. Golfier, F.

Source: Gynecologie Obstetrique & Fertilite. Jan2012, Vol. 40 Issue 1, p1-3. 3p.

Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer.

Authors: Glehen, O. Chapet, O. Adham, M. et al.

Source: British Journal of Surgery. Aug2003, Vol. 90 Issue 8, p996-998. 3p. 1 Graph.

The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry.

Authors: Villeneuve, L. Passot, G. Glehen, O. et al.

Source: Orphanet Journal of Rare Diseases. 2/17/2017, Vol. 12, p1-9. 9p.

Pouch adenocarcinoma after restorative proctocolectomy for familial adenomatous polyposis.

Authors: Cherki, S. Glehen, O. Moutardier, V. et al.

Source: Colorectal Disease. Nov2003, Vol. 5 Issue 6, p592. 2p. 1 Chart.

A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis.

Authors: Arjona-Sanchez, A. Esquivel, J. Glehen, O. et al.

Source: Surgical Endoscopy & Other Interventional Techniques. Mar2019, Vol. 33 Issue 3, p854-860. 7p. 5 Charts, 1 Graph.

Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin.

Authors: Laplace, N. Kepenekian, V. Friggeri, A. et al.

Source: International Journal of Hyperthermia. 2020, Vol. 37 Issue 1, p897-902. 6p. 1 Diagram, 3 Charts, 1 Graph.

Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer.

Authors: Gouy, S. Ferron, G. Glehen, O. et al.

Source: Gynecologic Oncology. Aug2016, Vol. 142 Issue 2, p237-242. 6p.

Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?

Authors: Honoré, C. Atallah, V. Mir, O. et al.

Source: PLoS ONE. 2/24/2017, Vol. 12 Issue 2, p1-12. 12p.

RAS mutation for metastatic colorectal cancer treated with potentially curative intent: impact of metastasis site.

Authors: Passot, G. Kim, B. Glehen, O. et al.

Source: HPB (1365-182X). 2019 Supplement3, Vol. 21, pS955-S956. 2p.

Long-term results of intrathoracic chemohyperthermia (ITCH) for the treatment of pleural malignancies.

Authors: Monneuse, O Beaujard, A C Guibert, B et al.

Source: British Journal of Cancer. 6/16/2003, Vol. 88 Issue 12, p1839-1843. 5p.

Prospective correlation of the radiological, surgical and pathological findings in patients undergoing cytoreductive surgery for colorectal peritoneal metastases: implications for the preoperative estimation of the peritoneal cancer index.

Authors: Bhatt, A. Rousset, P. Benzerdjeb, N. et al.

Source: Colorectal Disease. Dec2020, Vol. 22 Issue 12, p2123-2132. 10p.

Development and internal validation of a diagnostic score for gastric linitis plastica.

Authors: Vivier-Chicoteau, J. Lambert, J. Coriat, R. et al.

Source: Gastric Cancer. Jul2020, Vol. 23 Issue 4, p639-647. 9p.